Neurocrine Bioscience buy Canaccord Genuity Group Inc.
Start price
30.03.23
/
50%
€89.90
Target price
30.03.24
€120.95
Performance (%)
47.22%
End price
01.04.24
€132.35
Summary
This prediction ended on 01.04.24 with a price of €132.35. The BUY prediction by Canaccord_Genuity_Gr for Neurocrine Bioscience saw massive gains of 47.22%. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | 2.873% | 2.873% | 46.328% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $132.00 price target on the stock, up previously from $124.00.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten